The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Duchenne Muscular Dystrophy (DMD) Idea Development Award for fiscal year 2024, aimed at promoting innovative research that could significantly advance treatment options for individuals affected by DMD. This grant supports high-risk, high-reward research projects that are in the early stages of development, with a focus on generating impactful data and new avenues of investigation, particularly for new investigators transitioning into DMD research. The total estimated funding for this program is $4.48 million, with a maximum award amount of $350,000 over a two-year period, and applications must be submitted by August 22, 2024, following a pre-application deadline of August 1, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.